Skip to main content

Eslicarbazepine Acetate

NDC 60505-4661 · Apotex Corp.

Generic nameEslicarbazepine Acetate
Dosage formTABLET
RouteORAL
Active ingredient(s)ESLICARBAZEPINE ACETATE
Strength800 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

60505-4661-3 — 30 TABLET in 1 BOTTLE (60505-4661-3)

60505-4661-9 — 90 TABLET in 1 BOTTLE (60505-4661-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59651-534 — ESLICARBAZEPINE ACETATE, 59651-535 — ESLICARBAZEPINE ACETATE, 59651-536 — ESLICARBAZEPINE ACETATE, 59746-717 — eslicarbazepine acetate, 59746-718 — eslicarbazepine acetate, 59746-719 — eslicarbazepine acetate, 59746-720 — eslicarbazepine acetate, 60505-4658 — Eslicarbazepine Acetate, 60505-4659 — Eslicarbazepine Acetate, 60505-4660 — Eslicarbazepine Acetate, 63402-202 — ESLICARBAZEPINE ACETATE, 63402-204 — ESLICARBAZEPINE ACETATE, 63402-206 — ESLICARBAZEPINE ACETATE, 63402-208 — ESLICARBAZEPINE ACETATE, 67877-585 — Eslicarbazepine Acetate, 67877-586 — Eslicarbazepine Acetate, 67877-587 — Eslicarbazepine Acetate, 67877-588 — Eslicarbazepine Acetate, 68180-290 — Eslicarbazepine Acetate, 68180-291 — Eslicarbazepine Acetate, +19 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.